Axis Max Life Insurance.
Axis Max Life Insurance Limited ("Axis Max Life" / "Company"), formerly known as Max Life Insurance Company Limited, has launched the Axis Max Life Diversified Equity Fund II <SFIN: ULIF04317/12/25DIVIEQUITY104>. This New Fund Offer (NFO) is designed to capitalize on long-term capital appreciation by investing in a robust portfolio of high-growth companies across the market spectrum. The NFO period is open till April 27, 2026.
The Axis Max Life Diversified Equity Fund II is benchmarked against the NSE Nifty 200 Index. With a mandate to maintain a minimum of 80% exposure to equities, the fund aims to outperform the market through high-conviction stock picking and rigorous fundamental research. The remaining 20% of the corpus provides the flexibility to invest in debt instruments and money market papers to balance the portfolio's risk-return profile.
The fund builds upon the success of the existing Diversified Equity Fund <SFIN: ULIF02201/01/20LIFEDIVEQF104>, which recently received a 4-star rating from Morningstar for its consistent outperformance of the Nifty 200 Index across multiple market cycles.
Key Features of the Fund:
Sachin Bajaj, Executive Vice President & Chief Investments Officer, Axis Max Life Insurance, said: "In today's dynamic markets, our Diversified Equity Fund focuses on a multi-cap approach to unlock strong long-term value by harnessing opportunities across all market caps. This fund is relevant now more than ever, providing the agility required to mitigate concentration risks while capturing upside potential."
Customers can access the New Fund Offer by visiting - Axis Max Life Diversified Equity Fund II
Axis Max Life Insurance Limited, formerly known as Max Life Insurance Company Ltd., is a Joint Venture between Max Financial Services Limited ("MFSL") and Axis Bank Limited. Axis Max Life offers comprehensive protection and long-term savings life insurance solutions through its multi-channel distribution, including agency and third-party partners. Over two decades, the Company has built its operations on a need-based sales process, a customer-centric engagement model and trained human capital. As per audited financials for FY2024-25, Axis Max Life recorded a gross written premium of INR 33,223 crore.
IRDAI Registration No.: 104
Company Information Number: U74899HR2000PLC143012
Disclaimer: The information provided on the Website does not constitute investment advice, financial advice, trading advice, or any other form of advice, and you should not interpret any of the financial content as such. Please conduct your own due diligence and consult with a financial advisor before making any investment decisions. Midday does not endorse or promote any such activities, and you access them at your own risk, fully understanding the monetary and legal consequences involved. Midday shall not be held responsible for any losses you may incur as a result of using any such apps or websites.
